Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Leiomyosarcoma × PTC596 × Clear all

Phase

Phase 2/3 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leiomyosarcoma 1

Interventions

Doxorubicin 2 pazopanib 1 Trabectedin 1 Radiotherapy 1 Radiation 1 PTC596 1 Ifosfamide 1 Dacarbazine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05269355 2025-06-13

SUNRISELMS

PTC Therapeutics

Phase 2/3 Terminated

359 enrolled 15 charts

Leiomyosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡